Cargando…
Potential of Novel Methyl Jasmonate Analogs as Anticancer Agents to Metabolically Target HK-2 Activity in Glioblastoma Cells
Change in the energy metabolism of cancer cells, which display significant differences compared to normal cells, is a rising phenomenon in developing new therapeutic approaches against cancers. One of the metabolic enzymes, hexokinase-II (HK-II) is involved in glycolysis, and inhibiting the HK-II ac...
Autores principales: | Uludağ, Damla, Bay, Sadık, Sucu, Bilgesu Onur, Şavluğ İpek, Özgecan, Mohr, Thomas, Güzel, Mustafa, Karakaş, Nihal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9168889/ https://www.ncbi.nlm.nih.gov/pubmed/35677429 http://dx.doi.org/10.3389/fphar.2022.828400 |
Ejemplares similares
-
Novel Synthetic Approaches for Bisnaphthalimidopropyl (BNIP) Derivatives as Potential Anti-Parasitic Agents for the Treatment of Leishmaniasis
por: Keskin, Elif, et al.
Publicado: (2019) -
Synthesis of novel oxadiazole derivatives and their cytotoxic activity against various cancer cell lines
por: SUCU, Bilgesu Onur, et al.
Publicado: (2022) -
Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives
por: Karakaş, Nihal, et al.
Publicado: (2022) -
Discovery of a small molecule that selectively destabilizes Cryptochrome 1 and enhances life span in p53 knockout mice
por: Gul, Seref, et al.
Publicado: (2022) -
Exploring the prognostic value of HK3 and its association with immune infiltration in glioblastoma multiforme
por: Yang, Yuling, et al.
Publicado: (2023)